248 related articles for article (PubMed ID: 20137093)
21. Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET/CT: a prospective study.
Brændengen M; Hansson K; Radu C; Siegbahn A; Jacobsson H; Glimelius B
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e439-45. PubMed ID: 21641122
[TBL] [Abstract][Full Text] [Related]
22. Target volume delineation for preoperative radiotherapy of rectal cancer: inter-observer variability and potential impact of FDG-PET/CT imaging.
Krengli M; Cannillo B; Turri L; Bagnasacco P; Berretta L; Ferrara T; Galliano M; Gribaudo S; Melano A; Munoz F; Sciacero P; Tseroni V; Bassi MC; Brambilla M; Inglese E
Technol Cancer Res Treat; 2010 Aug; 9(4):393-8. PubMed ID: 20626204
[TBL] [Abstract][Full Text] [Related]
23. The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer.
Vanuytsel LJ; Vansteenkiste JF; Stroobants SG; De Leyn PR; De Wever W; Verbeken EK; Gatti GG; Huyskens DP; Kutcher GJ
Radiother Oncol; 2000 Jun; 55(3):317-24. PubMed ID: 10869746
[TBL] [Abstract][Full Text] [Related]
24. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
Ashamalla H; Rafla S; Parikh K; Mokhtar B; Goswami G; Kambam S; Abdel-Dayem H; Guirguis A; Ross P; Evola A
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1016-23. PubMed ID: 15979817
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of FDG-PET for defining gross tumor volume of head and neck cancer.
Kajitani C; Asakawa I; Uto F; Katayama E; Inoue K; Tamamoto T; Shirone N; Okamoto H; Kirita T; Hasegawa M
J Radiat Res; 2013 Jul; 54(4):671-8. PubMed ID: 23287772
[TBL] [Abstract][Full Text] [Related]
26. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging.
Scarfone C; Lavely WC; Cmelak AJ; Delbeke D; Martin WH; Billheimer D; Hallahan DE
J Nucl Med; 2004 Apr; 45(4):543-52. PubMed ID: 15073248
[TBL] [Abstract][Full Text] [Related]
27. [Impact of PET/CT on precise radiotherapy planning for non-small cell lung cancer].
Gong HY; Yu JM; Fu Z; Li BS; Li JB; Liu TH
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):54-7. PubMed ID: 16737623
[TBL] [Abstract][Full Text] [Related]
28. Comparison of CT and integrated PET-CT based radiation therapy planning in patients with malignant pleural mesothelioma.
Pehlivan B; Topkan E; Onal C; Nursal GN; Yuksel O; Dolek Y; Yavuz MN; Yavuz AA
Radiat Oncol; 2009 Sep; 4():35. PubMed ID: 19758456
[TBL] [Abstract][Full Text] [Related]
29. Role of PET/CT in treatment planning for head and neck cancer patients undergoing definitive radiotherapy.
Arslan S; Abakay CD; Sen F; Altay A; Akpinar T; Ekinci AS; Esbah O; Uslu N; Kekilli KE; Ozkan L
Asian Pac J Cancer Prev; 2014; 15(24):10899-903. PubMed ID: 25605198
[TBL] [Abstract][Full Text] [Related]
30. Clinical validation of FDG-PET/CT in the radiation treatment planning for patients with oesophageal cancer.
Muijs CT; Beukema JC; Woutersen D; Mul VE; Berveling MJ; Pruim J; van der Jagt EJ; Hospers GA; Groen H; Plukker JT; Langendijk JA
Radiother Oncol; 2014 Nov; 113(2):188-92. PubMed ID: 25467002
[TBL] [Abstract][Full Text] [Related]
31. Impact of (18)F-FDG-PET/CT on staging and irradiation of patients with locally advanced rectal cancer.
Paskeviciute B; Bölling T; Brinkmann M; Rudykina G; Ernst I; Stegger L; Schober O; Willich N; Weckesser M; Könemann S
Strahlenther Onkol; 2009 Apr; 185(4):260-5. PubMed ID: 19370430
[TBL] [Abstract][Full Text] [Related]
32. FET-PET for malignant glioma treatment planning.
Niyazi M; Geisler J; Siefert A; Schwarz SB; Ganswindt U; Garny S; Schnell O; Suchorska B; Kreth FW; Tonn JC; Bartenstein P; la Fougère C; Belka C
Radiother Oncol; 2011 Apr; 99(1):44-8. PubMed ID: 21458093
[TBL] [Abstract][Full Text] [Related]
33. The role of
Najem E; Marin T; Zhuo Y; Lahoud RM; Tian F; Beddok A; Rozenblum L; Xing F; Moteabbed M; Lim R; Liu X; Woo J; Lostetter SJ; Lamane A; Chen YE; Ma C; El Fakhri G
Radiother Oncol; 2024 May; 194():110186. PubMed ID: 38412906
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of Time-Phase Effect on 18F-FDG PET/CT Delineation Methods for Treatment Planning of Nasopharyngeal Carcinoma.
Chen YZ; Li WF; Wang JY; Wang JM; Ou RY; Zheng XW; Xu YS; Zhao L
Clin Nucl Med; 2016 May; 41(5):354-61. PubMed ID: 26859212
[TBL] [Abstract][Full Text] [Related]
35. PET-CT fusion in radiation management of patients with anorectal tumors.
Anderson C; Koshy M; Staley C; Esiashvili N; Ghavidel S; Fowler Z; Fox T; Esteves F; Landry J; Godette K
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):155-62. PubMed ID: 17707268
[TBL] [Abstract][Full Text] [Related]
36. Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer.
Grills IS; Yan D; Black QC; Wong CY; Martinez AA; Kestin LL
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):709-19. PubMed ID: 17197120
[TBL] [Abstract][Full Text] [Related]
37. Primary tumor delineation based on (18)FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy.
Leclerc M; Lartigau E; Lacornerie T; Daisne JF; Kramar A; Grégoire V
Radiother Oncol; 2015 Jul; 116(1):87-93. PubMed ID: 26088157
[TBL] [Abstract][Full Text] [Related]
38. Role of computed tomography and [18F] fluorodeoxyglucose positron emission tomography image fusion in conformal radiotherapy of non-small cell lung cancer: a comparison with standard techniques with and without elective nodal irradiation.
Ceresoli GL; Cattaneo GM; Castellone P; Rizzos G; Landoni C; Gregorc V; Calandrino R; Villa E; Messa C; Santoro A; Fazio F
Tumori; 2007; 93(1):88-96. PubMed ID: 17455878
[TBL] [Abstract][Full Text] [Related]
39. Radiotherapy planning: PET/CT scanner performances in the definition of gross tumour volume and clinical target volume.
Brianzoni E; Rossi G; Ancidei S; Berbellini A; Capoccetti F; Cidda C; D'Avenia P; Fattori S; Montini GC; Valentini G; Proietti A; Algranati C
Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1392-9. PubMed ID: 16133395
[TBL] [Abstract][Full Text] [Related]
40. Impact of 18F-FDG PET/CT on target volume delineation in recurrent or residual gynaecologic carcinoma.
Vees H; Casanova N; Zilli T; Imperiano H; Ratib O; Popowski Y; Wang H; Zaidi H; Miralbell R
Radiat Oncol; 2012 Oct; 7():176. PubMed ID: 23088346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
